Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A friendly reminder for HIV patients

13.09.2005


In a study from Johns Hopkins, a pocket-size device giving electronic-voice reminders to "take your medicine" proves to be a success for people living with HIV whose memory is slightly impaired by the virus.



The investigators report that the device, dubbed "Jerry" by most users, is a portable gadget programmed to ease the task of taking medicines in multiple doses every day on time. HIV-infected patients, particularly those suffering from mild memory loss from the disease, benefit highly from Jerry’s friendly reminders, according to a study published in the Sept. 15 issue of the journal Clinical Infectious Diseases.

Like an alarm clock, Jerry, more properly known as Disease Management Assistance System (DMAS), flashes a light and verbally tells the patient the exact dosage and medication to take at the correct time. DMAS is rechargeable and weighs about as much as a cell phone. Its computer programming keeps track of the patient’s compliance, allowing the doctor to download and print a report for monitoring the patient’s adherence to the medication schedule.


"One of the biggest reasons HIV patients cite for not taking their medication is just plain forgetfulness," says Adriana Andrade, M.D., M.P.H., assistant professor at the Johns Hopkins University Division of Infectious Diseases. "We thought a verbal reminder would be the best possible solution."

According to Andrade, treating HIV can be a grueling task for patients who must follow a hectic pill schedule, a combination of drugs called highly active antiretroviral therapy (HAART). Those who miss their medication a few times quickly develop a viral resistance to the drug, a problem since replacement options are few.

"On average, HIV-infected, treatment-naïve patients today take roughly two pills once a day, a significant decrease from a few years ago, when patients had to juggle dozens of medications per week," says Andrade. "But with all the regimens, patients must adhere to their medication faithfully because the virus easily develops a resistance, more so than most infectious diseases."

HIV can cause brain damage, making it more difficult for some patients to remember their HAART regimen, which is often different for every patient.

"We recruited patients with either normal memory or mild memory impairment for the study," says Andrade. "The results indicate that both groups adhered to their medication more so than not with Jerry, but the memory-impaired patients showed a greater improvement."

Fifty-eight of 64 patients completed the four-month study. Half of the patients were given a Jerry device and attended adherence counseling sessions, while the other half received only counseling. Those with Jerry took their medication 80 percent of the time, while those without did so only 65 percent of the time.

Of the 31 memory-impaired patients, those using Jerry had a 77 percent adherence rate, while those without Jerry had a 57 percent adherence rate, a 20 percent difference. The remaining patients with normal memory also adhered more with Jerry, but there was not a significant variance from those without the device, according to the researchers.

Throughout the study, all patients were given plasma viral load tests, which measure the amount of HIV in the blood. However, there was no significant difference in lessening the HIV amount between those with or without Jerry, according to the researchers.

"Hopefully, other devices like the DMAS will be further evaluated in similar studies, while incorporating the recent technologies of the two-way pager, cell phones or special alarm clocks," says Andrade.

The DMAS used in this study was manufactured by Adherence Technologies.

David March | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>